Copyright ©ERS Journals Ltd 2001 Audit of acute admissions of COPD: standards of care and management in the hospital setting1 Clinical Effectiveness and Evaluation unit, Royal College of Physicians, London and Whipps Cross Hospital, London, UK, 2 Aintree Chest Centre, University Hospital, Aintree, Liverpool, UK and 3 Hairmyres Hospital, East Kilbride, UK CORRESPONDENCE: C.M. Roberts, Chest Clinic, Whipps Cross Hospital, London,, E11 1NR, UK. Fax: 44 2085356709 Keywords: audit, chronic obstructive lung disease, management guidelines
Received: April 27, 2000
Despite publication of several management guidelines for COPD, relatively little is known about standards of care in clinical practice. Data were collected on the management of 1400 cases of acute admission with Chronic Obstructive Pulmonary Disease in 38 UK hospitals to compare clinical practice against the recommended British Thoracic Society standards. Variation in the process of care between the different centres was analysed and a comparison of the management by respiratory specialists and nonrespiratory specialists made. There were large variations between centres for many of the variables studied. A forced expiratory volume in one second measurement was found in only 53% of cases. Of the investigations recommended in the acute management arterial blood gases were performed in 79% (interhospital range 40100%) of admissions and oxygen was formally prescribed in only 64% (range 994%). Of those cases with acidosis and hypercapnia 35% had no further blood gas analysis and only 13% received ventilatory support. Long-term management was also deficient with 246 cases known to be severely hypoxic on admission yet two-thirds had no confirmation that oxygen levels had returned to levels above the requirements for long-term oxygen therapy. Only 30% of current smokers had cessation advice documented. To conclude, the median standards of care observed fell below those recommended by the guidelines. The lowest levels of performance were for patients not under the respiratory specialists, but specialists also have room for improvement. The substantial variation in the process of care between hospitals is strong evidence that it is possible for other centres with poorer performance to improve their levels of care. Chronic obstructive pulmonary disease (COPD) has a high prevalence and is one of the most common causes of emergency medical admission with a respiratory disorder in the UK 1, 2. Several national and international Thoracic Bodies have produced management guidelines 37 but relatively little is known about the standards of care of COPD as practised. Published studies encompass few hospitals, small patient numbers, and are not measured against nationally agreed standards. For example data from a sample of l00 cases from the West of Scotland suggested that care by respiratory specialists was better than that given by generalists 8. A study from a single New Zealand hospital concluded that process of care was "adequate" measured against a local consensus view 9. Following the launch of the British guidelines 7 the British Thoracic Society (BTS) performed an audit of the clinical practise of hospital care of patients admitted with acute exacerbations of COPD. The aims of the audit were to establish data on the current management of acute COPD in UK hospitals judged against the British guidelines and to identify differences in management between respiratory and nonrespiratory specialists.
Hospitals within the UK with acute Respiratory Medicine Departments were approached to participate in the study. All were asked to complete retrospective audit sheets from information held in case-note records on 40 consecutive admissions from September 1, 1997 with a clinical diagnosis of acute exacerbation of COPD as the admission criterion. The audit proforma developed by the BTS audit group, comprised 38 questions some with two or more stems covering the following areas of care: 1) background information and history prior to admission; 2) assessment and measurements on admission; 3) initial management; 4) continuing management and discharge, which included identifying the consultant responsible at the point of discharge as a respiratory specialist or other specialist; 5) follow-up in the three months after admission. The following standards were taken from the BTS guidelines for the five sections.
Background information
Assessment and measurements on admission
Initial management Blood gas tensions should be repeated if initially patient is acidotic or hypercapnic, nebulized bronchodilators should be given, antibiotics and steroids administered where appropriate, ventilatory support (noninvasive positive pressure ventilation (NIPPV) or via endotracheal tube) should be considered in those with a pH<7.26 and a rising arterial carbon dioxide tension (Pa,CO2).
Continuing management and discharge
Follow-up The audit proforma was accompanied by a detailed explanation of the reasoning for each question, possible answers, and guidance on where such information might be found within the case notes. Each centre nominated a consultant lead to be responsible for data quality and collection. A small payment was made on receipt of the completed audit forms. In order to check quality control five sets of case notes from each participating site were audited by a second observer usually a doctor in training from the same department.
Statistics A comparative analysis was performed on the data collected for continuing management and discharge between those cared for by specialist physicians and nonspecialist physicians. P-values from Chi-squared tests of significance and 95% confidence intervals (CI) for the difference between group percentages were calculated. This section of the analysis was limited to those aspects of patient care that might reasonably be expected to form the responsibility of the consultant in charge at the time of discharge. This was because the audit form asked specifically for this information and not the specialty under which the patient was admitted.
Forty-three centres submitted audit data for analysis. Fourteen were University teaching hospitals and the remainder district hospitals. A total of 1,400 cases were available for analysis, median contribution 40 per centre, IQR 2640. Dates of admission were known for all but one and 90% of admissions occurred during the months of September, October, and November 1997. Twenty-seven patients were included twice in the audit as re-admissions during the counting of consecutive cases. Thus, there were a total of 1,373 different patients included in all. For the analysis of the standards of care all 1,400 admissions are included and may be referred to as "cases".
Table 1
Assessment and measurement on admission The audit questionnaire examined, the documentation of three symptoms; "increased breathlessness"; "increased sputum volume"; and "change in colour of sputum". Relevant entries were found in almost all cases for "increased breathlessness" but in only about two-thirds of cases for the other two symptoms. Respiratory rate was recorded in 70% (982) of all cases, presence or absence of bilateral leg oedema in 66% (923), and temperature in 86% (1209) (table 2
A comment on the chest radiograph was recorded within the first 24 h in 65% (916) of cases and described infiltrates in a quarter of these. Arterial oxygen saturation (Sa,O2) was recorded by pulse oximetry in 76% (1061/1400) of admissions and was whilst breathing room air in 26% (275). Arterial blood gases, were performed in 79% (1109) of admissions. The inspired oxygen concentration was noted in 71% (786/1109) of these with 27% (296) breathing room air. In 19 cases an Sa,O2 of 92% was recorded but no arterial blood gas was performed.
Initial management, within the first 24 h of admission Repeat arterial blood gases were performed in 34%, (371) of cases (interhospital range 062%, IQR 1944%), within 24 h of admission. They were more likely to be repeated in the acidotic patient. Nebulized bronchodilators were documented as given in 91% (1267/1400) of admissions. A ß2-agonist was used with an anticholinergic in 17% (979/1267) of cases, a ß2-agonist alone in 17% (215) and an anticholinergic alone in 2% (28) whilst in 4% the type was unknown. Systemic steroids and antibiotics were given to the majority of patients.
Assisted ventilation (either invasive positive pressure ventilation (IPPV) or NIPPV) was used in 3% of cases (hospital range 011%, IQR 05%). Frequency of use was unaffected by first or re-admission but was more likely to be used in the acidotic patient (table 3
Continuing management A chart peak flow record to assess reversibility was kept in only a half of cases and a third overall had neither a peak flow chart or evidence of FEV1 recorded within 5 yrs or 3 months after the admission. Inhaler technique was infrequently assessed and smoking cessation advice rarely given and documented in the case notes. Documentation of vaccination advice recommendation of pulmonary rehabilitation and formal reversibility testing was poor.
In the first time admissions there were higher rates of checking inhaler technique (28 versus 16%) and of giving smoking cessation advice to current smokers (34 versus 28%). For those with previous admissions there were higher rates in the recording of FEV1 (58 versus 47%) reversibility testing (bronchodilators: 29 versus 25%, steroids: 8 versus 6%), vaccination advice (4.9 versus 4.3%) and pulmonary rehabilitation advice (3.2 versus 2.0%). Rates for outpatient follow-up were identical These differences are not unexpected and are of little clinical significance (table 4
A Pa,O2 on admission of <7.3 kPa was documented in 246 cases and few of these had a subsequent Pa,O2 >7.3 kPa whilst breathing room air recorded in the case notes. Eighteen per cent (254) received oxygen when discharged stated as a concentrator in 111 cases and cylinder in 90. This included 68 of the cases with an admission Pa,O2<7.3 kPa. Out of 797 given outpatient follow-up 57% (458) attended, 23% (181) did not, 8% (66) were readmitted and no information was available for the remaining 12%. At the time of discharge 43% (602/1400) cases were under the care of a Chest Physician, 20% (277) under a Geriatrician and 32% (450 cases) under another speciality physician.
Comparison of respiratory and nonrespiratory specialist care
The severity of COPD when a measured FEV1 was available was compared between the two managed groups using a two-sample t-test. For male cases FEV1 (L) Respiratory specialists 1.07±0.59, nonRespiratory specialists 1.09±0.54 p=0.74, CI 0.10.1. FEV1 % pred value 39% and 41% respectively, p=0.43, CI 73%. For female cases the more severe cases were biased towards the Respiratory specialists. For example FEV1 Respiratory specialists 0.78±0.38, and non-Respiratory specialists 0.86±0.40 p=0.07, CI 0.20.1 L. As % pred, Respiratory specialists 38% and non-Respiratory specialists 47%, p=0.002, CI 143% (table 5
This audit of the management of 1,400 cases of COPD admitted to hospitals throughout the UK has demonstrated deficiencies in standards of care measured against the BTS management guidelines as well as wide variations of process of care between hospitals that cannot be explained by known case-mix variables. Nearly half did not have objective confirmation of the diagnosis documented. Investigations recommended to optimize emergency management were often not performed, and later interventions that might influence the prognosis of the disease were not made (tables 3 and 4
The audit inclusion criterion was a clinical diagnosis of COPD at discharge. The BTS guidelines recommend confirmation of clinical diagnosis by spirometry. Whilst this simple investigation is available in every hospital and the audit protocol accepted an FEV1 recorded within the 5 yrs prior to admission or in the 3 months following admission, only 53% of cases had this documented. In only 37% (514) of all cases was this available as a percentage of the predicted mean value that is used to classify the severity of the condition. Of these 26 (5%) had a value >80% pred i.e. did not have COPD by the BTS criteria but still had this diagnostic label at discharge. The peak expiratory flow was recorded in 46% of cases on admission and a chart record vital to assess therapeutic response was kept in just 51% of cases. A formal reversibility test to bronchodilators or steroids was documented in 27% and 7% of cases respectively. Chest physicians were more likely to have confirmed the diagnosis of COPD than other specialists (71 versus 41% table 5
Initial assessment The variability between centres in recording arterial blood gas analysis was 40100% (IQR 7390%) A formal prescription specifying inspired oxygen level was documented in only 64% of cases with a huge interhospital variation (994% IQR 5377%). Type II respiratory failure is a fairly common and treatable sequel to acute exacerbations of COPD however, of those with acidosis and hypercapnoea, over one-third failed to receive follow-up arterial blood gas analysis to monitor progress and only 13% received ventilatory support. This failure of management may suggest a nihilistic approach and occurred in spite of the good evidence that even in severe COPD the outcome following interventions for acute deteriorations is good 11.
Long-term planning
Comparison with other studies There are limitations to this study that require discussion. A high proportion of admissions were not the first inpatient episode for these cases and some of the absent documentation of interventions may have been made previously. A retrospective audit of case notes will inevitably contain some inaccuracies and depends upon the case note recording by doctors. In medico-legal terms absence of documentation implies absence of process. Quality of collected data depended upon those completing the audit forms and several levels of control were instituted. The power of the study comes from the large sample size and the number and variety of contributing centres. Results from this study will help to form a future COPD audit tool which will be brief and have easily collectable data, reproducible from one hospital centre to another, designed for routine prospective use in hospital medical departments.
Implications for the future These data reflect the performance of hospitals and not of individuals. Each hospital in this audit received an individual report showing its performance against national averages. This form of benchmarking can be easily understood by medical and nonmedical staff 22. Poorly performing units should examine data recording, staffing, organizational issues as well as management protocols and clinical competence.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||